BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Thyroid cancer AND BRCA2, FAD, 675, ENSG00000139618, FACD, FAD1, FANCD, FANCD1, BRCC2, RP11-298P3_4 AND Prognosis
1722 results:

  • 1. Next-generation sequencing identified that RET variation associates with lymph node metastasis and the immune microenvironment in thyroid papillary carcinoma.
    Huang Y; Lin P; Liao J; Liang F; Han P; Fu S; Jiang Y; Yang Z; Tan N; Huang J; Chen R; Ouyang N; Huang X
    BMC Endocr Disord; 2024 May; 24(1):68. PubMed ID: 38734621
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Identification and validation of a prognostic anoikis-related gene signature in papillary thyroid carcinoma by integrated analysis of single-cell and bulk RNA-sequencing.
    Zheng K; Zhang XX; Yu X; Yu B; Yang YF
    Medicine (Baltimore); 2024 May; 103(19):e38144. PubMed ID: 38728457
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Prognostic value of postoperative anti-thyroglobulin antibody in patients with differentiated thyroid cancer.
    Zhao Y; Mu Z; Liang D; Zhang T; Zhang X; Sun D; Sun Y; Liang J; Lin Y
    Front Endocrinol (Lausanne); 2024; 15():1354426. PubMed ID: 38721144
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Time Kinetics and prognosis roles of calcitonin after surgery for medullary thyroid carcinoma.
    Guo F; Fu G; Li F; Hua Y; Wang Z; Zheng X; Zhao J; Gao M
    World J Surg Oncol; 2024 May; 22(1):121. PubMed ID: 38711029
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Factors influencing TSH suppression efficacy in postoperative papillary thyroid carcinoma patients: a retrospective cohort study.
    Zhang Q; Zhong ZZ; Wu T; He YQ
    BMC Surg; 2024 May; 24(1):133. PubMed ID: 38702652
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Deubiquitination of CDC6 by OTUD6A promotes tumour progression and chemoresistance.
    Cui J; Liu X; Shang Q; Sun S; Chen S; Dong J; Zhu Y; Liu L; Xia Y; Wang Y; Xiang L; Fan B; Zhan J; Zhou Y; Chen P; Zhao R; Liu X; Xing N; Wu D; Shi B; Zou Y
    Mol Cancer; 2024 Apr; 23(1):86. PubMed ID: 38685067
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. PON3::LCN1 and HTN3::MSANTD3 Gene Fusions With NR4A3/NR4A2 Expression in Salivary Acinic Cell Carcinoma.
    Zhu L; Sun L; Zhang Y; Liu X; Li X; Zhou Z; Cui Y; Zhou CX; Li TJ
    Am J Surg Pathol; 2024 Jun; 48(6):681-690. PubMed ID: 38682454
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Identification of 10 differentially expressed and cuproptosis-related genes in immune infiltration and prognosis of thyroid carcinoma.
    Yu W; Liu H; Zhang Y; Liu M; Li W; Wang L; Li D
    Cell Mol Biol (Noisy-le-grand); 2024 Mar; 70(3):89-94. PubMed ID: 38650151
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Activation of the YY1-UGT2B7 Axis Promotes Mammary Estrogen Homeostasis Dysregulation and Exacerbates Breast Tumor Metastasis.
    Xu J; Zhou Y; He S; Wang Y; Ma J; Li C; Liu Z; Zhou X
    Drug Metab Dispos; 2024 Apr; 52(5):408-421. PubMed ID: 38575184
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Development and validation of a nomogram for predicting lymph node metastasis in ductal carcinoma in situ with microinvasion: A SEER population-based study.
    Zhu K; Sui Y; Zhu M; Gao Y; Yuan Y; Sun P; Meng L; Dai J; Li Z
    PLoS One; 2024; 19(4):e0301057. PubMed ID: 38557552
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. BRAF
    Zhao H; Liu CH; Lu Y; Liu SZ; Yeerkenbieke P; Cao Y; Xia Y; Gao LY; Liu YW; Liu ZW; Chen SG; Liang ZY; Li XY
    Oral Oncol; 2024 May; 152():106755. PubMed ID: 38547780
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Cyto-Histological Profile of MicroRNAs as Diagnostic Biomarkers in Differentiated thyroid Carcinomas.
    Matos ML; Pinto M; Alves M; Canberk S; Gonçalves A; Bugalho MJ; Papoila AL; Soares P
    Genes (Basel); 2024 Mar; 15(3):. PubMed ID: 38540448
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Osteopontin promotes tumor growth and metastasis and GPX4-mediated anti-lipid peroxidation in triple-negative breast cancer by activating the PI3k/Akt/mTOR pathway.
    Guo M; Liu M; Li W; Wang C; Zhang L; Zhang H
    J Cancer Res Clin Oncol; 2024 Mar; 150(3):155. PubMed ID: 38526702
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Elevated PDE4C level serves as a candidate diagnostic biomarker and correlates with poor survival in thyroid carcinoma.
    Wang Y; Zhang Y; Li Y; Huang J
    Sci Rep; 2024 Mar; 14(1):6813. PubMed ID: 38514754
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. The potential value of ultrasound in predicting local refractory/relapse events in primary thyroid lymphoma patients.
    Ji J; Gao L; Liu R; Shi X; Ma L; Pan A; Li N; Liu C; Li X; Yang M; Xia Y; Jiang Y
    Cancer Imaging; 2024 Mar; 24(1):39. PubMed ID: 38509603
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Clinicopathological features and prognostic value of CD276 expression in female reproductive system malignancies: A meta-analysis.
    Su H; Hao JJ; Xu YB; Zhang FH
    Taiwan J Obstet Gynecol; 2024 Mar; 63(2):154-160. PubMed ID: 38485307
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Nitric oxide nano-reactor DNMF/PLGA enables tumor vascular microenvironment and chemo-hyperthermia synergetic therapy.
    Wang R; Cheng L; He L; Du C; Wang H; Peng B; Yu X; Liu W; Luo W; Ran H; Yang L
    J Nanobiotechnology; 2024 Mar; 22(1):110. PubMed ID: 38481281
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. PLK4 reflects extrathyroidal invasion, high tumor stage and poor prognosis in papillary thyroid carcinoma patients.
    Hu X; Yu J; Chen M; Pang R
    Biomark Med; 2024 Mar; 18(5):169-179. PubMed ID: 38440866
    [No Abstract]    [Full Text] [Related]  

  • 19. Transoral laser microsurgery for T1 glottic cancer with anterior commissure: Identifying clinical and radiological variables that predict oncological outcome.
    Eker C; Surmelioglu O; Dagkiran M; Kaya O; Tanrisever I; Arpaci B; Kaya B; Yucel Karakaya SP; Onan E
    Eur Arch Otorhinolaryngol; 2024 May; 281(5):2597-2608. PubMed ID: 38424299
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Surrogate endpoints in clinical trials of p16-positive squamous cell carcinoma of the oropharynx: an individual patient data meta-analysis.
    Gharzai LA; Morris E; Suresh K; Nguyen-Tân PF; Rosenthal DI; Gillison ML; Harari PM; Garden AS; Koyfman S; Caudell JJ; Jones CU; Mitchell DL; Krempl G; Ridge JA; Gensheimer MF; Bonner JA; Filion E; Dunlap NE; Stokes WA; Le QT; Torres-Saavedra P; Mierzwa M; Schipper MJ
    Lancet Oncol; 2024 Mar; 25(3):366-375. PubMed ID: 38423050
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 87.